Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spinocerebellar ataxia type 3 (Machado-Joseph disease).
Dulski J, Al-Shaikh RH, Sulek A, Kasprzak J, Sławek J, Wszolek ZK. Dulski J, et al. Among authors: kasprzak j. Pol Arch Intern Med. 2022 Oct 21;132(10):16322. doi: 10.20452/pamw.16322. Epub 2022 Aug 22. Pol Arch Intern Med. 2022. PMID: 35997122 Free article. No abstract available.
Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study.
Przytuła F, Kasprzak J, Dulski J, Koziorowski D, Kwaśniak-Butowska M, Sołtan W, Roszmann A, Śmiłowska K, Schinwelski M, Sławek J. Przytuła F, et al. Among authors: kasprzak j. Parkinsonism Relat Disord. 2023 Jan;106:105238. doi: 10.1016/j.parkreldis.2022.105238. Epub 2022 Dec 6. Parkinsonism Relat Disord. 2023. PMID: 36509028 Free PMC article.
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies - real-world data from the IG TATRY study.
Heropolitańska-Pliszka E, Pac M, Pietrucha B, Machura E, Pukas-Bochenek A, Chrobak E, Bień E, Malanowska M, Pituch-Noworolska A, Drygała S, Kamieniak M, Kasprzak J, Mach-Tomalska M. Heropolitańska-Pliszka E, et al. Among authors: kasprzak j. Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1281-1291. doi: 10.1080/1744666X.2023.2240514. Epub 2023 Jul 25. Expert Rev Clin Immunol. 2023. PMID: 37489744
Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases.
Mach-Tomalska M, Pituch-Noworolska A, Bień E, Malanowska M, Machura E, Pukas-Bochenek A, Chrobak E, Pac M, Pietrucha B, Drygała S, Kamieniak M, Kasprzak J, Heropolitańska-Pliszka E. Mach-Tomalska M, et al. Among authors: kasprzak j. Immunotherapy. 2024 Apr;16(6):391-403. doi: 10.2217/imt-2023-0305. Epub 2024 Feb 16. Immunotherapy. 2024. PMID: 38362629 Free article.
Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO Multicenter Study.
Gąsior T, Zaborska B, Stachowiak P, Sikora-Frąc M, Mizia-Stec K, Kasprzak J, Bodys A, Bijoch J, Szmagała A, Kosior DA, Płońska-Gościniak E. Gąsior T, et al. Among authors: kasprzak j. J Clin Med. 2024 Apr 26;13(9):2543. doi: 10.3390/jcm13092543. J Clin Med. 2024. PMID: 38731072 Free PMC article.
Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.
Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA. Zenga J, et al. Among authors: kasprzak j. Transl Oncol. 2024 Jun;44:101927. doi: 10.1016/j.tranon.2024.101927. Epub 2024 Mar 8. Transl Oncol. 2024. PMID: 38641374 Free article. No abstract available.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
595 results